Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| certolizumab pégol | est un(e) (attribut) | Product containing tumor necrosis factor alpha inhibitor (product) | true | Inferred relationship | Some | ||
| certolizumab pégol | est un(e) (attribut) | Inflammatory bowel disease drug (product) | false | Inferred relationship | Some | ||
| certolizumab pégol | est un(e) (attribut) | Product containing monoclonal antibody (product) | true | Inferred relationship | Some | ||
| certolizumab pégol | a pour principe actif (attribut) | Certolizumab pegol (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only certolizumab pegol (medicinal product) | est un(e) (attribut) | True | certolizumab pégol | Inferred relationship | Some | |
| Product containing certolizumab pegol in parenteral dose form (medicinal product form) | est un(e) (attribut) | True | certolizumab pégol | Inferred relationship | Some | |
| Certolizumab pegol 200mg powder for injection solution vial + diluent (product) | est un(e) (attribut) | False | certolizumab pégol | Inferred relationship | Some | |
| Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | est un(e) (attribut) | False | certolizumab pégol | Inferred relationship | Some |
This concept is not in any reference sets
FHIR